ClinicalTrials.gg
Enrolling by invitationNCT07839728PHRESUpdated Sep 24, 2026

Study of the Prevalence of Postoperative Hypothermia in Adults Undergoing Non-Cardiac Surgery in Spanish Post-Anesthesia Care Units

An observational study in Hypothermia Following Anesthesia, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Enrolling by invitation at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
1,300
Ages
18 Years and older
Sex
All
01

Study summary

The prevalence of Hypothermia in Spanish Post-Anesthesia Recovery Units (in Spanish: "Prevalencia de Hipotermia en las Reanimaciones Españolas" PHRES Study) is a prospective, multicenter observational study that will evaluate how often adults develop unintended low body temperature after non-cardiac surgery in post-anesthesia recovery units in Spain.

Unintended low body temperature, known as perioperative hypothermia, is a common problem after surgery and may be associated with complications such as shivering, increased bleeding, heart problems, discomfort, and delayed recovery. Although active warming devices and temperature monitoring are available in many Spanish hospitals, their use may vary between centers.

The study will include adults undergoing scheduled non-cardiac surgery lasting more than 60 minutes under general, regional, or combined anesthesia. Approximately 1,334 patients from 25-30 Spanish hospitals are expected to participate.

Patients will be included consecutively according to predefined eligibility criteria. The study will record information about the patient, the type and duration of surgery and anesthesia, and the measures used to prevent low body temperature before and during surgery, including active warming and temperature monitoring.

On arrival in the post-anesthesia recovery unit, the patient's core body temperature will be measured using the same non-invasive temperature monitoring technology in all participating centers. The main objective is to determine the proportion of patients with a core temperature below 36°C at the time of admission to the recovery unit.

The study will also investigate factors associated with postoperative hypothermia and record complications occurring shortly after surgery, such as shivering, hemodynamic instability, new-onset arrhythmias, significant bleeding, and the need for blood transfusion.

This is an observational study. The study will not determine or change how patients are warmed or how their temperature is monitored during surgery. These decisions will remain the responsibility of the treating anesthesia team according to local clinical practice. The additional temperature measurement performed for the study is non-invasive and does not involve any significant additional risk to participants.

Read the detailed description

Background

Unintended perioperative hypothermia, defined as a core body temperature below 36.0°C, is one of the most common complications associated with anesthesia and surgery. During the first hour after induction of anesthesia, the body's normal temperature regulation is impaired, causing heat to redistribute from the core to the peripheral tissues. Additional factors such as exposure to a cool operating room, administration of intravenous fluids, surgical duration, and the extent of the surgical procedure further increase the risk of heat loss.

Postoperative hypothermia has been associated with several adverse outcomes, including shivering, patient discomfort, increased blood loss and transfusion requirements, wound infection, cardiac complications, and prolonged recovery. International guidelines recommend routine temperature monitoring and the use of active warming techniques during surgery. However, the implementation of these recommendations varies considerably between hospitals, and contemporary national data from Spain are not available.

The PHRES Study has been designed to determine the current prevalence of postoperative hypothermia in Spanish post-anesthesia recovery units and to describe perioperative temperature management practices across a wide range of hospitals.

Study Design

PHRES is a prospective, multicenter, observational study conducted in approximately 25-30 public and private hospitals throughout Spain. The study is coordinated by Spanish anesthesiologists and will recruit approximately 1,334 adult patients undergoing elective non-cardiac surgery.

Because this is an observational study, no aspect of routine clinical care will be modified. Decisions regarding prewarming, intraoperative active warming, temperature monitoring, fluid warming, anesthetic technique, and postoperative management will remain entirely under the responsibility of the treating anesthesia team according to local clinical practice.

Participants

Eligible participants are adults aged 18 years or older undergoing scheduled non-cardiac surgery with an expected anesthesia duration of more than 60 minutes. Patients receiving general anesthesia, neuraxial anesthesia, or combined techniques may be included. Patients with suspected infection, those undergoing surgery under regional anesthesia with sedation alone, or those unable to provide informed consent will be excluded.

Participants will be enrolled consecutively during predefined recruitment periods in each participating center in order to minimize selection bias.

Study Procedures

After written informed consent is obtained, demographic and clinical information will be collected from the medical record and anesthesia chart. Information recorded will include:

  • Patient characteristics and comorbidities.
  • Type and duration of anesthesia and surgery.
  • Surgical specialty and operative approach.
  • Use of preoperative and intraoperative active warming.
  • Methods of intraoperative core temperature monitoring.
  • Administration of fluids, vasoactive drugs, and irrigation fluids.

Upon admission to the post-anesthesia care unit (PACU), the patient's core temperature will be measured using the same non-invasive zero-heat-flux temperature monitoring system in all participating centers. Standardizing the postoperative temperature measurement minimizes variability related to different thermometry methods and allows reliable comparison between hospitals.

The study will also record immediate postoperative events including shivering, hemodynamic instability requiring vasoactive support, new-onset arrhythmias, significant bleeding, and the need for blood transfusion.

Study Objectives

The primary objective is to estimate the prevalence of postoperative hypothermia, defined as a core temperature below 36.0°C at admission to the PACU.

Secondary objectives are:

  • To describe the use of prewarming, active intraoperative warming, and core temperature monitoring in Spanish hospitals.
  • To identify patient- and procedure-related risk factors associated with postoperative hypothermia.
  • To evaluate the relationship between postoperative hypothermia and immediate postoperative complications.

Importance of the Study

This study will provide the first large contemporary national estimate of postoperative hypothermia in Spain using a standardized method for postoperative core temperature measurement. The results are expected to identify opportunities to improve perioperative temperature management, promote adherence to evidence-based warming strategies, and ultimately improve patient safety and recovery after surgery.

02

Conditions studied

  • Hypothermia Following Anesthesia

Browse trials for

Keywords

  • inadverted postoperative hypothermia
03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 1,300 is above the median of 95 across 106 observational studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz is the lead sponsor of 76 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients undergoing scheduled non-cardiac surgery under general, neuraxial, or combined anesthesia at participating public or private hospitals in Spain. Participating centers will be hospitals with operating rooms equipped with active patient warming systems and availability of core temperature monitoring in the postoperative recovery setting.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) physical status I-III.
  • Scheduled for non-cardiac surgical procedure.
  • Anesthesia duration >60 minutes.
  • General anesthesia, neuraxial anesthesia, or combined general and neuraxial/peripheral nerve block anesthesia.
  • Written provided by the participant.

Exclusion criteria

Exclusion Criteria:

  • Signs or suspicion of active infection at the time of surgery.
  • Surgical procedure performed under regional anesthesia with sedation only.
  • Cognitive impairment preventing the participant from understanding the study information.
  • Refusal to participate in the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
1,300 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • DevicePostoperative temperature monitoring

    A non-invasive zero-heat-flux temperature sensor will be used to measure core body temperature upon admission to the post-anesthesia care unit. The same temperature monitoring system will be used in all participating centers to standardize postoperative temperature measurement. The measurement does not alter routine clinical care.

06

What researchers measure

Primary outcomes

  1. Prevalence of Postoperative Hypothermia

    Proportion of patients with a core body temperature below 36.0°C at admission to the post-anesthesia care unit (PACU). Core temperature will be measured using a non-invasive zero-heat-flux temperature monitoring system.

    Time frame: At admission to the post-anesthesia care unit, immediately after surgery

Secondary outcomes

  1. Prevalence of Preoperative Active Warming

    Proportion of patients who receive active warming for at least 10 minutes before transfer to the operating room.

    Time frame: During the preoperative period, before transfer to the operating room

  2. Prevalence of Intraoperative Active Warming

    Proportion of patients who receive active intraoperative warming and description of the warming method used, including forced-air warming, conductive warming, intravenous fluid warming, or irrigation fluid warming.

    Time frame: From induction of anesthesia until completion of surgery

  3. Prevalence of Intraoperative Core Temperature Monitoring

    Proportion of patients who undergo intraoperative core temperature monitoring and description of the monitoring method used.

    Time frame: During surgery

  4. Risk Factors Associated With Postoperative Hypothermia

    Association between patient characteristics, comorbidities, surgical and anesthetic characteristics, and perioperative temperature management practices and the occurrence of postoperative hypothermia, defined as core temperature below 36.0°C at admission to the PACU.

    Time frame: Perioperative/Periprocedural

  5. Immediate Postoperative Complications Associated With Hypothermia

    Association between postoperative hypothermia and immediate postoperative complications, including shivering, hemodynamic instability requiring vasoactive drugs, new-onset perioperative arrhythmia, perioperative bleeding greater than 500 mL, and need for blood transfusion.

    Time frame: Perioperative/Periprocedural

07

Study locations

1 site
08

References and documents

Publications

  • Pedersen C, Munch P, Kjaergaard J, Gronlykke L, Brauer A. Accuracy of a zero-heat-flux thermometer in cardiac surgery, a prospective, multicentre, method comparison study. Sci Rep. 2024 Feb 7;14(1):3169. doi: 10.1038/s41598-024-53647-3. PubMed 38326589 ↗
  • Alfonsi P, Bekka S, Aegerter P; SFAR Research Network investigators. Prevalence of hypothermia on admission to recovery room remains high despite a large use of forced-air warming devices: Findings of a non-randomized observational multicenter and pragmatic study on perioperative hypothermia prevalence in France. PLoS One. 2019 Dec 23;14(12):e0226038. doi: 10.1371/journal.pone.0226038. eCollection 2019. PubMed 31869333 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared because of privacy and data protection considerations. The study involves health-related information that will be collected and pseudonymized in accordance with applicable data protection regulations. Data will be used for the purposes specified in the study protocol and will not be made available for public sharing at the individual participant level.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

Of 47 non-industry observational studies under Hypothermia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 50. This study's planned 1 month is below that.

Counting every sponsor, half of 48 studies reached it within 12 months; a quarter within 4 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2026
First posted
Sep 24, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jan 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07839728
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Sep 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion